[1]
Zavrelova, A. et al. 2022. BETTER OUTCOME OF HIGH-DOSE CEFTAZIDIME IN HEMATO – ONCOLOGICAL PATIENTS WITH INFECTIONS CAUSED BY EXTENSIVELY DRUG-RESISTANT PSEUDOMONAS AERUGINOSA. Mediterranean Journal of Hematology and Infectious Diseases. 15, 1 (Dec. 2022), e2023001. DOI:https://doi.org/10.4084/MJHID.2023.001.